NCT07082270 2026-04-15Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple MyelomaRoswell Park Cancer InstitutePhase 1 Withdrawn
NCT04447716 2025-09-15An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to TreatmentThomas Jefferson UniversityPhase 1 Active not recruiting4 enrolled